Biden Admin To INCREASE Drug Prices – Reversing Trump Policy Designed To Lower Insulin Prices

President Trump’s policies continue to reveal what destroyers and enemies of the people the Democrats are.

President Biden has been reversing or pausing some rules put in place under former President Donald Trump this week, including one designed to bring down the price of insulin.

To those 80M that voted for Biden. Pls explain how INCREASING the price of Insulin for those that need it is a Win?

— Fadde (@fadde) January 23, 2021

Look, America did not vote for
Unemployment
High taxes
Communist China
ISIS
Iran
Federal mask mandates
Rampant illegal immigration
Amnesty
Paris Climate rape job
Jihad immigration
Jew hatred
US troop deployments to third world USA-hating shitholes

The election was stolen.

— 🇺🇸 GELLER REPORT 🇺🇸 (@PamelaGeller) January 23, 2021

Biden admin freezes Trump HHS rule meant to lower insulin prices

The rule has been put on hold for 60 days pending review

By Brittany De Lea | Fox News January 23, 2020:

Is Biden’s rush to reverse Trump policies in nation’s best interest?

FOX News Washington correspondent Rich Edson details the foreign policy concerns on ‘Special Report’

President Biden has been reversing or pausing some rules put in place under former President Donald Trump this week, including one designed to bring down the price of insulin.

The Department of Health and Human Services on Thursday announced that the directive would be put on hold among a number of other measures that were passed under Trump, but are not yet in effect.

The measure, signed off on in December, aimed to require some community health centers to deliver savings to low-income patients for insulin and epinephrine in a bid to bring down unaffordable prices.

The rule was scheduled to go into effect on Friday but has since been delayed until March 22.

On Wednesday, White House chief of staff Ron Klain directed agencies to pause orders signed towards the end of Trump’s term so they could be reviewed.

The order directs the administration to immediately withdraw rules that have been sent to the Office of Financial Research but not yet published in the Federal Register. For those that have been published, but are not yet effective, members are directed to “consider postponing the rules’ effective dates for 60 days.”

EDIOTRS NOTE: This Geller Report column is republished with permission. ©All rights reserved. Quick note: Tech giants are snuffing us out. You know this. Facebook, Twitter, Google et al have shadowbanned, suspended and in some cases deleted us from your news feeds. They are disappearing us. But we are here. Subscribe to Geller Report newsletter here— it’s free and it’s critical NOW more than ever.

---